Menu
Google life sciences group to wage war on diabetes

Google life sciences group to wage war on diabetes

Google will work with drug maker Sanofi on digitizing the process of managing diabetes

Google may still be working on a name for its recently spun off life sciences group, but the division already has a foe: diabetes.

On Monday, Google said the chronic disease will be the first illness the life sciences division focuses on as it becomes a separate business under the new Alphabet holding company.

The search giant also wants to digitize how people manage their diabetes and is partnering with drug maker Sanofi to develop technologies that could aid in that process.

Diabetics use mobile apps, medical devices and even pieces of paper to record food intake, log blood sugar levels, track fitness activities and determine medication doses, Google said. Given the hassles of using these unintegrated methods, only around half of diabetics achieve their target glucose levels, according to a study from The New England Journal of Medicine that was cited by Google.

The medical consequences of not managing diabetes include heart disease, stroke and nerve damage.

Since the partnership is new, neither Google nor Sanofi could say exactly how the search giant's technology could be used by the pharmaceutical company. The goal, though, is to use Google technology including sensors, wearable devices and analytics tools to give doctors and patients more insight into how to better manage diabetes.

For example, the technology could help explain to a physician why a person's glucose level has spiked for several days or provide real-time information related to a patient's insulin dosage or diet.

Google Life Sciences chief Andy Conrad [cq] told Bloomberg smart insulin and measurement devices could come out of the partnership.

The deal's financial terms weren't disclosed.

Google's life sciences group has made other forays into diabetes research. The company is working with drug company Novartis on creating a contact lens that uses tears to measure a person's blood sugar levels. Earlier this month, Google and medical device maker Dexcom said they would collaborate on creating a small sensor that would continuously monitor a person's glucose levels and be connected to the cloud.

Once part of the secretive Google X research lab, the life sciences unit became its own company under a massive reorganization at the search giant. A name hasn't been selected for the new venture.

Subscribe here for up-to-date channel news

Follow Us

Join the New Zealand Reseller News newsletter!

Error: Please check your email address.

Tags Google

Featured

Slideshows

Tight lines as Hooked on Lenovo catches up at Great Barrier Island

Tight lines as Hooked on Lenovo catches up at Great Barrier Island

​Ingram Micro’s Hooked on Lenovo incentive programme recently rewarded 28 of New Zealand's top performing resellers with a full-on fishing trip at Great Barrier Island for the third year​ in a row.

Tight lines as Hooked on Lenovo catches up at Great Barrier Island
Inside the AWS Summit in Sydney

Inside the AWS Summit in Sydney

As the dust settles on the 2017 AWS Summit in Sydney, ARN looks back an action packed two-day event, covering global keynote presentations, 80 breakout sessions on the latest technology solutions, and channel focused tracks involving local cloud stories and insights.

Inside the AWS Summit in Sydney
Channel tees off on the North Shore as Ingram Micro hosts annual Cure Kids Charity golf day

Channel tees off on the North Shore as Ingram Micro hosts annual Cure Kids Charity golf day

Ingram Micro hosted its third annual Cure Kids Charity Golf Tournament at the North Shore Golf Club in Auckland. In total, 131 resellers, vendors and Ingram Micro suppliers enjoyed a round of golf consisting of challenges on each of the 18 sponsored holes, with Team Philips taking out the top honours.

Channel tees off on the North Shore as Ingram Micro hosts annual Cure Kids Charity golf day
Show Comments